Erosive Gastroduodenitis with Marked Epithelial Atypia after Hepatic Arterial Infusion Chemotherapy

Jewell, L. D.; Fields, A. L.; Murray, C. J. W.; Thomson, A. B. R.
June 1985
American Journal of Gastroenterology;Jun1985, Vol. 80 Issue 6, p421
Academic Journal
We report the case of a 59-year-old man who was treated with intraarterial chemotherapy for metastatic colonic adenocarcinoma. After the second course he developed persistent symptoms of nausea, vomiting, and pain. Endoscopic examination demonstrated severe erosive gastritis and duodenitis, and histological examination of the antral tissue showed severe atypia and histological appearances suggestive of in situ carcinoma. A 2-month course of sucralfate and cimetidine was used and successfully produced symptomatic relief as well as complete normalization of the dysplastic changes.


Related Articles

  • WHAT'S NEW IN DRUGS. Rodman, Morton J.; Scholz, Mary J. // RN;Feb88, Vol. 51 Issue 2, p97 

    Provides an update on drugs in the U.S. as of February 1988. Findings of a clinical trial on chemotherapy for breast cancer; Facts on the use of sucralfate for patients undergoing mechanical ventilation; Treatment for reflex sympathetic dystrophy.

  • Bevacizumab.  // Reactions Weekly;9/1/2007, Issue 1167, p8 

    The article presents a case study of a 53-year old man with adenocarcinoma of the colon and has developed nasal septum perforation and fusariosis during treatment with bevacizumab for unresectable lung progression. The man started an LV5FU2 chemotherapy regimen and afterwards reported occasional...

  • Lentivirus-Mediated RNA Interference of HMGA1 Promotes Chemosensitivity to Gemcitabine in Pancreatic Adenocarcinoma Liau, Siong-Seng; Ashley, Stanley W.; Whang, Edward E. // Journal of Gastrointestinal Surgery;Nov2006, Vol. 10 Issue 9, p1254 

    The high mobility group A1 (HMGA1) proteins are overexpressed in pancreatic cancers. They are architectural nuclear proteins, which regulate expression of multiple genes implicated in the malignant phenotype. In this study, we hypothesized that HMG A1 silencing will promote chemosensitivity in...

  • Ovarian clear cell adenocarcinoma: a continuing enigma. Tan, David S. P.; Kaye, Stan // Journal of Clinical Pathology;Apr2007, Vol. 60 Issue 4, p355 

    Ovarian clear cell adenocarcinomas (OCCAs) account for <5% of all ovarian malignancies. Compared to other epithelial ovarian cancer (EOC) subtypes, when at an advanced stage, they are associated with a poorer prognosis and are relatively resistant to conventional platinum-based chemotherapy. By...

  • Smoking reduces survival in young females with lung adenocarcinoma after curative resection. Liu, Ming; Jiang, Gening; Ding, Jiaan; Fan, Jiang; He, Wenxin; Zhang, Peng; Song, Nan // Medical Oncology;Jun2012, Vol. 29 Issue 2, p570 

    The aim of this study was to investigate effects of smoking on the overall survival of young female lung adenocarcinoma patients after curative resection. A total of 282 surgically treated young females (younger than 40) with histologically confirmed primary lung adenocarcinoma were studied...

  • Synchronous colorectal cancer. Nikoloudis, N.; Saliangas, K.; Economou, A.; Andreadis, E.; Siminou, S.; Manna, I.; Georgakis, K.; Chrissidis, T. // Techniques in Coloproctology;Nov2004 Supplement 1, Vol. 8, ps177 

    Synchronous carcinomas of the colon and rectum are of considerable clinical significance because of their frequency, the number of extra tumours missed and the difficulty of preoperative diagnosis. A retrospective evaluation of 283 patients with primary colorectal adenocarcinomas was performed....

  • Leiomyosarcoma prostate: A rare case. Ramaswamy, Krishna Mohan; Ashish, Jindal; Poulose, Chally; Azeez, A. V. A.; Chally, R. // Indian Journal of Urology;Supplement1, Vol. 24, pS33 

    Introduction: Majority of malignant lesions of prostate are adenocarcinoma. Only 0.1 to 3.7% are sarcomas. Materials and Methods: A 59 year old male presented with GI symptoms initially and later urinary symptoms. On evaluation needle biopsy shows Leiomyosarcoma prostate (locally advanced)....

  • Review: Neoadjuvant chemoradiotherapy and chemotherapy improve survival in operable esophageal cancer: COMMENTARY. Javle, Milind; Yang, Gary Y. // ACP Journal Club;Jul/Aug2007, Vol. 147 Issue 1, p19 

    The authors reflect on a study, conducted by V. Gebski and colleagues, which discusses how neoadjuvant chemoradiotherapy or chemotherapy given before surgery increase survival in patients with esophageal cancer. He notes that on comparing chemotherapy with surgery Gebski and colleagues analyzed...

  • NON-SMALL CELL LUNG CANCER OPTIONS.  // Cortlandt Forum;7/25/2001, Vol. 14 Issue 7, p76 

    Focuses on treatment options for a nonsmoking patient diagnosed with stage 4 non-small cell carcinoma of the lung. Excise of metastatic brain adenocarcinoma; Experimental therapy; Novel chemotherapeutic agents.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics